Danaher (DHR) Stock on December 1, 2025: Q3 Beat, Legal Probes and Fresh Price Targets – Is the Premium Still Worth Paying?
Danaher Corporation (NYSE: DHR) enters December 2025 trading around the mid‑$220s per share, a high‑quality life‑sciences and diagnostics name that continues to command a premium valuation — and attract both bullish analysts and governance‑focused law firms.TS2+1 Below is a detailed, news‑driven overview of Danaher’s latest stock performance, legal and institutional developments, analyst forecasts and key themes to watch into 2026. Danaher stock today: price, valuation and trading context As of the U.S. session on December 1, 2025, Danaher is trading around $225 per share, with recent real‑time quotes in the ~$225–$225.50 range.MarketScreener Recent trading and valuation context: Danaher also pays